期刊文献+

Insulin resistance in development and progression of nonalcoholic fatty liver disease 被引量:14

Insulin resistance in development and progression of nonalcoholic fatty liver disease
下载PDF
导出
摘要 Although insulin resistance(IR)is strongly associated with nonalcoholic fatty liver disease(NAFLD),the association of IR and NAFLD is not universal and correlation between IR and severity of NAFLD is still controversial.In this review,we summarize recent evidence that partially dissociates insulin resistance from NAFLD.It has also been reported that single-nucleotide polymorphisms in the diacylglycerol acyltransferase gene,rather than IR,account for the variability in liver fat content.Polymorphisms of the patatin-like phospholipase 3 gene have also been reported to be associated with NAFLD without metabolic syndrome,which suggests that genetic conditions that promote the development of fatty changes in the liver may occur independently of IR.Moreover,environmental factors such as nutrition and physical activity as well as small intestinal bacterial overgrowth have been linked to the pathogenesis of NAFLD,although some of the data are conflicting.Therefore,findings from both genetically engineered animal models and humans with genetic conditions,as well as recent studies that have explored the role of environmental factors,have confirmed the view that NAFLD is a polygenic disease process caused by both genetic and environmental factors.Therefore,IR is not the sole predictor of the pathogenesis of NAFLD. Although insulin resistance (IR) is strongly associated with nonalcoholic fatty liver disease (NAFLD), the association of IR and NAFLD is not universal and correlation between IR and severity of NAFLD is still controversial. In this review, we summarize recent evidence that partially dissociates insulin resistance from NAFLD. It has also been reported that single-nucleotide polymorphisms in the diacylglycerol acyltransferase gene, rather than IR, account for the variability in liver fat content. Polymorphisms of the patatin-like phospholipase 3 gene have also been reported to be associated with NAFLD without metabolic syndrome, which suggests that genetic conditions that promote the development of fatty changes in the liver may occur independently of IR. Moreover, environmental factors such as nutrition and physical activity as well as small intestinal bacterial overgrowth have been linked to the pathogenesis of NAFLD, although some of the data are conflicting. Therefore, findings from both genetically engineered animal models and humans with genetic conditions, as well as recent studies that have explored the role of environmental factors, have confirmed the view that NAFLD is a polygenic disease process caused by both genetic and environmental factors. Therefore, IR is not the sole predictor of the pathogenesis of NAFLD.
出处 《World Journal of Gastrointestinal Pathophysiology》 CAS 2016年第2期211-217,共7页 世界胃肠病理生理学杂志(英文版)(电子版)
关键词 NONALCOHOLIC FATTY liver disease INSULIN resistance METABOLIC syndrome Diabetes NONALCOHOLIC STEATOHEPATITIS Nonalcoholic fatty liver disease Insulin resistance Metabolic syndrome Diabetes Nonalcoholic steatohepatitis
  • 相关文献

参考文献72

  • 1Stefano Romeo,Julia Kozlitina,Chao Xing,Alexander Pertsemlidis,David Cox,Len A Pennacchio,Eric Boerwinkle,Jonathan C Cohen,Helen H Hobbs.Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nature Genetics . 2008
  • 2Mohamed Asrih,Fran?ois R. Jornayvaz.??Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?(J)Molecular and Cellular Endocrinology . 2015
  • 3Stuart McPherson,Tim Hardy,Elsbeth Henderson,Alastair D. Burt,Christopher P. Day,Quentin M. Anstee.Evidence of NAFLD Progression from Steatosis to Fibrosing-Steatohepatitis Using Paired Biopsies: Implications for Prognosis & Clinical Management[J]. Journal of Hepatology . 2014
  • 4H. Perazzo,M. Munteanu,Y. Ngo,P. Lebray,N. Seurat,F. Rutka,M. Couteau,S. Jacqueminet,P. Giral,D. Monneret,F. Imbert‐Bismut,V. Ratziu,A. Hartemann‐Huertier,C. Housset,T. Poynard.Prognostic value of liver fibrosis and steatosis biomarkers in type‐2 diabetes and dyslipidaemia[J]. Aliment Pharmacol Ther . 2014 (9)
  • 5Matthew J. Armstrong,Leon A. Adams,Ali Canbay,Wing‐Kin Syn.??Extrahepatic complications of nonalcoholic fatty liver disease(J)Hepatology . 2014 (3)
  • 6Eugene Chang,Cheol‐Young Park,Sung Woo Park.??Role of thiazolidinediones, insulin sensitizers, in non‐alcoholic fatty liver disease(J)J Diabetes Invest . 2013 (6)
  • 7Angel Brea,José Puzo.??Non-alcoholic fatty liver disease and cardiovascular risk(J)International Journal of Cardiology . 2012
  • 8Kiran Bambha,Patricia Belt,Maria Abraham,Laura A. Wilson,Mark Pabst,Linda Ferrell,Aynur Unalp‐Arida,Nathan Bass.??Ethnicity and nonalcoholic fatty liver disease(J)Hepatology . 2012 (3)
  • 9Giovanni Musso,Roberto Gambino,Maurizio Cassader,Gianfranco Pagano.Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity[J].Annals of Medicine.2011(8)
  • 10Vernon G,Baranova A,Younossi Z M.Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Alimentary Pharmacology and Therapeutics . 2011

二级参考文献2

共引文献66

同被引文献66

引证文献14

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部